252 participants
A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2011-02-01
- Start Date:
- 2001-04-30
Conditions
- Leukemia, Nonlymphocytic, Acute
Interventions
- DRUG
No Results Yet